IL124444A0 - Biochemical approach to diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment - Google Patents
Biochemical approach to diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatmentInfo
- Publication number
- IL124444A0 IL124444A0 IL12444498A IL12444498A IL124444A0 IL 124444 A0 IL124444 A0 IL 124444A0 IL 12444498 A IL12444498 A IL 12444498A IL 12444498 A IL12444498 A IL 12444498A IL 124444 A0 IL124444 A0 IL 124444A0
- Authority
- IL
- Israel
- Prior art keywords
- predisposition
- epilepsy
- diagnosis
- monitoring
- biochemical approach
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2857—Seizure disorders; Epilepsy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12444498A IL124444A0 (en) | 1998-05-12 | 1998-05-12 | Biochemical approach to diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment |
JP2000548720A JP2002538412A (en) | 1998-05-12 | 1999-05-12 | Diagnosis of epilepsy predisposition and monitoring of antiepileptic treatment |
AU37277/99A AU3727799A (en) | 1998-05-12 | 1999-05-12 | Diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment |
CA002332021A CA2332021A1 (en) | 1998-05-12 | 1999-05-12 | Diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment |
EP99919514A EP1093580A4 (en) | 1998-05-12 | 1999-05-12 | Diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment |
PCT/IL1999/000252 WO1999058968A1 (en) | 1998-05-12 | 1999-05-12 | Diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12444498A IL124444A0 (en) | 1998-05-12 | 1998-05-12 | Biochemical approach to diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
IL124444A0 true IL124444A0 (en) | 1998-12-06 |
Family
ID=11071485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12444498A IL124444A0 (en) | 1998-05-12 | 1998-05-12 | Biochemical approach to diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1093580A4 (en) |
JP (1) | JP2002538412A (en) |
AU (1) | AU3727799A (en) |
CA (1) | CA2332021A1 (en) |
IL (1) | IL124444A0 (en) |
WO (1) | WO1999058968A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003032894A2 (en) * | 2001-10-12 | 2003-04-24 | Pfizer Products Inc. | Method of monitoring neuroprotective treatment |
AT9843U1 (en) | 2007-03-27 | 2008-04-15 | Kepplinger Berthold Dr | MEASUREMENT OF BIOLOGICAL MARKERS |
GB201211120D0 (en) * | 2012-06-22 | 2012-08-01 | Bessede Alban | Antagonist to an enzyme and/or a metabolite of the kynurenine pathway |
GB201322538D0 (en) | 2013-06-21 | 2014-02-05 | Immusmol Sas | Method for detecting small molecules in a sample |
EA201690217A1 (en) * | 2013-07-18 | 2016-07-29 | Дайэнти Мс Лимитэд | METHOD AND DIAGNOSTIC KIT FOR CONTROL OF MULTIPLE SCLEROSIS (PC) |
WO2019181830A1 (en) * | 2018-03-19 | 2019-09-26 | 富士フイルム和光純薬株式会社 | Method for judging psychiatric disorder |
-
1998
- 1998-05-12 IL IL12444498A patent/IL124444A0/en unknown
-
1999
- 1999-05-12 WO PCT/IL1999/000252 patent/WO1999058968A1/en not_active Application Discontinuation
- 1999-05-12 JP JP2000548720A patent/JP2002538412A/en active Pending
- 1999-05-12 CA CA002332021A patent/CA2332021A1/en not_active Abandoned
- 1999-05-12 EP EP99919514A patent/EP1093580A4/en not_active Withdrawn
- 1999-05-12 AU AU37277/99A patent/AU3727799A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU3727799A (en) | 1999-11-29 |
EP1093580A4 (en) | 2001-09-12 |
CA2332021A1 (en) | 1999-11-18 |
WO1999058968A1 (en) | 1999-11-18 |
JP2002538412A (en) | 2002-11-12 |
EP1093580A1 (en) | 2001-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL143825A0 (en) | System for scheduling and monitoring computer processes | |
IL128106A0 (en) | Non invasive continuous blood glucose monitoring | |
HUP9901993A3 (en) | Substituted aryl or heteroarylamides having retinoid-like biological activity | |
AU2003303597A8 (en) | Continuous glucose monitoring system and methods of use | |
GB9702202D0 (en) | Diagnosis of arthritic conditions | |
GB9807464D0 (en) | Purification of human acid µ-glucosidase | |
IL124444A0 (en) | Biochemical approach to diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment | |
HU9602536D0 (en) | Treatment of diabetic nephropathy with valsartan | |
GB2361872B (en) | Diagnosis of medical disorders | |
GB9820919D0 (en) | Diagnostic method | |
BR9707013A (en) | Process for monitoring biological activity of fluids | |
GB9805913D0 (en) | Diagnosis of ms | |
IL126681A0 (en) | Treatment of trauma-related conditions | |
EP1107778A4 (en) | Treatment of disease states | |
GB9614615D0 (en) | Diagnosis of pre-eclampsia | |
GB9922482D0 (en) | Method of diagnosis | |
GB9819370D0 (en) | Rate of change monitoring system | |
EP1101818A4 (en) | Method for enhancing catalytic activity of cells | |
NZ316343A (en) | Diagnosis of nonparaffinophilic microorganisms | |
ZA992251B (en) | Improved processes for synthesis and purification of nondigestible fats using lipase. | |
PL313420A1 (en) | Method of determining the activity index of active sludge biological processes | |
IL121656A0 (en) | Diagnosis prevention and treatment of diabetes | |
PL325794A1 (en) | Method of illuminating indicating elements and indicating element therefor | |
GB9621742D0 (en) | Diagnosis of diabetes | |
TW364307U (en) | Structure of crystal necklace |